Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan pediatric formulation BID vs TID in children with pulmonary arterial hypertension
CTR20132542Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Sep 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bosentan in pulmonary arterial hypertension (PAH), sponsored by Actelion Pharmaceuticals Ltd. Started Sep 2016; status: completed.
02
Drugs
bosentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on CTR20132542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132542.